Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 346

1.

Association between statin adherence and cholesterol level reduction from baseline in a veteran population.

Kazerooni R, Watanabe JH, Bounthavong M.

Pharmacotherapy. 2013 Oct;33(10):1044-52. doi: 10.1002/phar.1305. Epub 2013 Jun 6.

PMID:
23744794
2.

Association of copayment and statin adherence stratified by socioeconomic status.

Kazerooni R, Bounthavong M, Watanabe JH.

Ann Pharmacother. 2013 Nov;47(11):1463-70. doi: 10.1177/1060028013505743. Epub 2013 Oct 10.

PMID:
24259605
3.

Revisiting the medication possession ratio threshold for adherence in lipid management.

Watanabe JH, Bounthavong M, Chen T.

Curr Med Res Opin. 2013 Mar;29(3):175-80. doi: 10.1185/03007995.2013.766164. Epub 2013 Feb 1.

PMID:
23320610
4.

Association between persistence with statin therapy and reduction in low-density lipoprotein cholesterol level: analysis of real-life data from community settings.

Shalev V, Goldshtein I, Halpern Y, Chodick G.

Pharmacotherapy. 2014 Jan;34(1):1-8. doi: 10.1002/phar.1326. Epub 2013 Jul 8.

PMID:
23836549
6.

Association between short-term effectiveness of statins and long-term adherence to lipid-lowering therapy.

Benner JS, Pollack MF, Smith TW, Bullano MF, Willey VJ, Williams SA.

Am J Health Syst Pharm. 2005 Jul 15;62(14):1468-75.

PMID:
15998926
7.

Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.

Heintjes EM, Penning-van Beest FJ, Plat AW, Meerding WJ, Webb K, Sturkenboom MC, Herings RM.

Pharmacotherapy. 2012 Jul;32(7):631-41. doi: 10.1002/j.1875-9114.2011.01086.x.

PMID:
22760692
8.

HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.

Tani S, Nagao K, Hirayama A.

Am J Cardiovasc Drugs. 2011 Dec 1;11(6):411-7. doi: 10.2165/11594620-000000000-00000.

PMID:
22149320
9.

Association of copayment and socioeconomic status with hormonal contraceptive adherence in a female veteran population.

Kazerooni R, Vu K, Takizawa A, Broadhead C, Morreale AP.

Womens Health Issues. 2014 Mar-Apr;24(2):e237-41. doi: 10.1016/j.whi.2013.12.002. Epub 2014 Feb 16.

PMID:
24533983
10.
11.
12.

Non-high-density lipoprotein cholesterol reporting and goal attainment in primary care.

Virani SS, Wang D, Woodard LD, Chitwood SS, Landrum CR, Zieve FJ, Ballantyne CM, Petersen LA.

J Clin Lipidol. 2012 Nov-Dec;6(6):545-52. doi: 10.1016/j.jacl.2012.04.080. Epub 2012 Apr 24.

PMID:
23312050
13.

Association of polypharmacy and statin new-user adherence in a Veterans Health Administration population: a retrospective cohort study.

Watanabe JH, Bounthavong M, Chen T, Ney JP.

Ann Pharmacother. 2013 Oct;47(10):1253-9. doi: 10.1177/1060028013502000. Epub 2013 Oct 21.

PMID:
24259688
14.

Low high-density lipoprotein cholesterol is not a risk factor for recurrent vascular events in patients with vascular disease on intensive lipid-lowering medication.

van de Woestijne AP, van der Graaf Y, Liem AH, Cramer MJ, Westerink J, Visseren FL; SMART Study Group.

J Am Coll Cardiol. 2013 Nov 12;62(20):1834-41. doi: 10.1016/j.jacc.2013.04.101. Epub 2013 Aug 21.

15.

The association between achieving low-density lipoprotein cholesterol (LDL-C) goal and statin treatment in an employee population.

Burton WN, Chen CY, Schultz AB, Edington DW.

Popul Health Manag. 2010 Feb;13(1):1-8. doi: 10.1089/pop.2009.0020.

16.
17.

Adherence to statins and LDL-cholesterol goal attainment.

Chi MD, Vansomphone SS, Liu IL, Cheetham C, Green KR, Scott RD, Reynolds K.

Am J Manag Care. 2014 Apr 1;20(4):e105-12.

18.

Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.

Bullano MF, Wertz DA, Yang GW, Kamat S, Borok GM, Gandhi S, McDonough KL, Willey VJ.

Pharmacotherapy. 2006 Apr;26(4):469-78.

PMID:
16553504
19.

Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.

Nicholls SJ, Tuzcu EM, Sipahi I, Grasso AW, Schoenhagen P, Hu T, Wolski K, Crowe T, Desai MY, Hazen SL, Kapadia SR, Nissen SE.

JAMA. 2007 Feb 7;297(5):499-508.

PMID:
17284700
20.

The influence of statin medications on prostate-specific antigen levels.

Hamilton RJ, Goldberg KC, Platz EA, Freedland SJ.

J Natl Cancer Inst. 2008 Nov 5;100(21):1511-8. doi: 10.1093/jnci/djn362. Epub 2008 Oct 28.

PMID:
18957682

Supplemental Content

Support Center